Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Candi-5V by LimmaTech Biologics for Vulvovaginal Candidiasis: Likelihood of Approval
Candi-5V is under clinical development by LimmaTech Biologics and currently in Phase II for Vulvovaginal Candidiasis. According to GlobalData, Phase...